Thromb Haemost 1981; 45(02): 121-126
DOI: 10.1055/s-0038-1650147
Original Article
Schattauer GmbH Stuttgart

Plasminogen-Activator in Human Early Milk: Its Partial Purification and Characterization

Utako Okamoto
The Department of Physiology, Faculty of Nutrition, Kobe-Gakuin University, Kobe, Japan
,
Noboru Horie
The Department of Physiology, Faculty of Nutrition, Kobe-Gakuin University, Kobe, Japan
,
Yoko Nagamatsu
The Department of Physiology, Faculty of Nutrition, Kobe-Gakuin University, Kobe, Japan
,
Jun-Ichiro Yamamoto
The Department of Physiology, Faculty of Nutrition, Kobe-Gakuin University, Kobe, Japan
› Author Affiliations
Further Information

Publication History

Received 07 July 1980

Accepted 16 January 1981

Publication Date:
05 July 2018 (online)

Summary

Milk plasminogen-activator was partially purified from human transitional milk collected at about 10 days after delivery, by a five-step procedure involving chloroform treatment, ammonium sulfate precipitation, and column chromatography on Sephadex G-150, CM Sephadex C-50 and DEAE Sephadex A-50. This gave milk-activator with a maximum purification factor of about 2,400-fold with respect to the skimmed milk. The CM Sephadex-step preparation showed, on polyacrylamide gel electrophoresis, a single plasminogen-activator activity band located between the bands of albumin and prealbumin of human serum. This preparation exhibited no kinin forming activity. The activator hydrolyzed acetyl-glycyl-L-lysine methyl ester with similar order kinetic constants to urokinase, and was inhibited strongly by diisopropyl-fluorophosphate. The molecular weight of the activator as estimated by gel filtration was approximately 86,000, the isoelectric points as estimated by gel isoelectric focusing were pH 7.2, 6.9 and 6.6, and the activator activity was not quenched by antiurokinase globulin, indicating that the milk-activator is a different entity from urokinase.

 
  • References

  • 1 Sobel GW, Mohler SR, Jones W, Dowdy ABC, Guest MM. Urokinase, an activator of plasma fibrinolysin extracted from urine. Am J Physiol 1952; 171: 768-769
  • 2 Albrechtsen OK, Thaysen JH. Fibrinolytic activity in human saliva. Acta Physiol Scand 1955; 35: 138-145
  • 3 Rasumussen J, Albrechtsen OK. Fibrinolytic activity in human seminal plasma. Fert Steril 1960; 11: 264-277
  • 4 Oshiba S, Hata S, Okamoto S. A plasminogen activator in mammalian bile. Jpn J Physiol 1969; 19: 212-219
  • 5 Astrup T, Sterndorff I. A fibrinolytic system in human milk. Proc Soc Exp Biol Med 1953; 84: 605-607
  • 6 Okamoto U, Horie N, Nagamatsu Y, Yamamoto J. Distribution of plasminogen-activator in human milk samples collected at various days after delivery. Acta Haematol Jap 1980; 43: 743-746
  • 7 Deutsch DE, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
  • 8 Holmberg L, Bladh B, Åstedt B. Purification of urokinase by affinity chromatography. Biochem Biophys Acta 1976; 445: 215-222
  • 9 Astrup T, Müllertz S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys 1952; 40: 346-351
  • 10 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275
  • 11 Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Analyt Chem 1953; 28: 350-356
  • 12 Webster ME, Parado ES. Glandular kallikrein from horse and human urine and from hog pancreas. Methods in Enzymology, Academic Press; New York: 1970. 19. 681-699
  • 13 Siegelman AM, Carlson AS, Robertson T. Investigation of serum trypsin and related substances. I. The quantitative demonstration of trypsinlike activity in human blood serum by a micromethod. Arch Biochem Biophys 1962; 97: 159-163
  • 14 Johnson A, Kline DL, Alkjaersig N. Assay method and standard preparation for plasmin, plasminogen and urokinase in purified systems. Thromb Diath Haemorrh 1969; 21: 259-272
  • 15 Davis BJ. Disc electrophoresis II: Methods and application to human serum proteins. Ann N Y Acad Sci 1964; 121: 404-427
  • 16 Ornstein L. Disc electrophoresis I: Background and theory. Ann N Y Acad Sci 1964; 121: 321-349
  • 17 Weber K, Osborn M. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. J Biol Chem 1969; 244: 4406-4412
  • 18 Wrigley CW. Gel electrofocusing. Methods in Enzymology. Academic Press; New York: 1971. 22. 559-564
  • 19 Andrews P. Estimation of the molecular weights of proteins by Sephadex gel-filtration. Biochem J 1963; 91: 222-233
  • 20 Lineweaver H, Burk D. Determination of enzyme dissolution constants. J A Chem Soc 1934; 56: 658-666
  • 21 Pedersen VE, Keil-Dlouha V, Keil B. On the properties of trypsin inhibitors from human and bovine colostrum. FEBS Letters 1971; 17: 23-26
  • 22 Yamamoto J, Horie N, Okamoto U. Enzymatic properties of milk activator in relation to synthetic chromogenic substrates. Thromb Res 1980; 18: 263-266
  • 23 Lesuk AL, Terminiello L, Traver JH, Groff JL. Biochemical and biophysical studies of human urokinase. Thromb Diath Haemorrh 1967; 18: 293-294
  • 24 Ali SY, Evans L. Purification of rabbit kidney cytokinase and a comparison of its properties with human urokinase. Biochem J 1968; 107: 293-303
  • 25 Oshiba S, Ariga T. Purification and characterization of bilokinase, a biliary plasminogen activator. Thromb Diath Haemorrh 1975; 34: 319
  • 26 Propping D, Zaneveld LJ D, Tauber PF, Schumacher GF B. Purification of plasminogen activators from human seminal plasma. Biochem J 1978; 171: 435-444
  • 27 Hijikata A, Fujimoto K, Kitaguchi H, Okamoto S. Some properties of tissue plasminogen activator from the pig heart. Thromb Res 1974; 4: 731-740
  • 28 Cole ER, Bachmann W. Purification and properties of a plasminogen activator from pig heart. J Biol Chem 1977; 252: 3729-3737
  • 29 Rijken DC, Wijngaards G, Zaal-De Jong M, Welbergen J. Purification and partial characterization of plasminogen activator from human uterine tissue. Biochim Biophys Acta 1979; 580: 140-153
  • 30 Wallen P, Rånby M, Bergsdorf N, Kok P. Purification of porcine and human tissue activator. Thromb Haemostas 1979; 42: 414
  • 31 Kok P. Purification and properties of a porcine tissue plasminogen activator and its comparison with activators from human uterine tissue, blood and urine. Thromb Haemostas 1979; 42: 413
  • 32 Aoki N. Preparation of plasminogen activator from vascular trees of human cadavers. Its comparison with urokinase. J Biochem 1974; 75: 731-741
  • 33 Binder BR, Spragg J, Austen F. Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates. J Biol Chem 1979; 254: 1998-2003
  • 34 Binder BR, Spragg J. Purification of a plasminogen activator from venous occlusion plasma. Thromb Haemostas 1979; 42: 362
  • 35 Cole E, Snopko R. Comparative isoelectric focusing properties of plasminogen activators from porcine and human tissues. Thromb Haemostas 1979; 42: 413
  • 36 Kucinsky CS, Fletcher AP, Sherry S. Effect of urokinase antiserum on plasminogen activators: Demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase. J Clin Invest 1968; 47: 1238-1253
  • 37 Rijken DC, Wijngaards G. Plasminogen activators in human seminal plasma. Thromb Haemostas 1979; 42: 292
  • 38 Colman RW. Activation of plasminogen by human kallikrein. Biochem Biophys Res Commun 1969; 35: 273-279